Arlington, VA, United States of America

Chetana M Revankar


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2011-2013

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Chetana M Revankar: Innovator in Molecular Biology and Pharmacology

Introduction

Chetana M Revankar is a prominent inventor based in Arlington, VA (US). She has made significant contributions to the field of molecular biology and pharmacology, particularly through her innovative research and patented inventions. With a total of 2 patents, her work focuses on developing compounds that interact with estrogen receptors and GPR30, which are crucial in treating various disease states.

Latest Patents

Revankar's latest patents include groundbreaking compounds designed for binding to estrogen receptors alpha (ERα), beta (ERβ), and GPR30. These compounds are aimed at modulating the effects of these receptors, which play a vital role in numerous health conditions. The inventions address a wide range of diseases, including various cancers, reproductive disorders, cardiovascular conditions, and neurodegenerative diseases. Additionally, her work includes contraceptive applications to prevent or reduce the likelihood of pregnancy after intercourse.

Career Highlights

Chetana M Revankar has established herself as a leading figure in her field through her innovative research and dedication to improving health outcomes. Her work has the potential to impact the treatment of hormone-dependent cancers, reproductive health issues, and various neurological disorders.

Collaborations

Revankar has collaborated with notable colleagues, including Eric R Prossnitz and Sergey E Tkatchenko, further enhancing the scope and impact of her research.

Conclusion

Chetana M Revankar's contributions to molecular biology and pharmacology exemplify the importance of innovation in addressing complex health challenges. Her patented inventions hold promise for advancing treatment options and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…